UB research may offer a more streamlined approach to developing cancer drugs

Drug discovery can be a frustrating process of trial and error.

Targeting intracellular checkpoints to enhance NK cell immunotherapy

Natural killer (NK) cells are pivotal in the innate immune response against cancer and viral infections, with their presence in tumors correlating to better patient

November 28, 2024

Bayer partners with RNA startup launched out of Dana-Farber

Even as Bayer continues cutting costs across its conglomerate, it’s still making some small R&D deals to add to its pipeline. On Wednesday, the German

August 29, 2024

Drug price increases layered over decades: AARP analysis shows how list prices can rise by more than 700%

A new AARP analysis released Thursday shows how list prices for the 25 top Medicare Part D drugs increased by an average of 226% since

August 11, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.